Hansoh Pharmaceutical Group Company Ltd
Hansoh Pharmaceutical Group's Climate Target Data Preview
As of 2024, Hansoh Pharmaceutical Group has disclosed 1 climate targets aimed at reducing its greenhouse gas (GHG) emissions. These include 1 intensity-based target, signaling the company's commitment to managing and lowering its carbon footprint over time. The targets span various emissions scopes and time horizons, offering insight into Hansoh Pharmaceutical Group's climate strategy, ambition level, and alignment with global decarbonization goals.
| Target Type | Scope of Target | Unit | Target | Target Year |
|---|---|---|---|---|
Intensity-based Target | Scope 1 - Total, Scope 2 - Total | Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue | Copy/Paste is a PRO feature.  a | 2030 |
Verified Sources Behind Hansoh Pharmaceutical Group’s Climate Targets Data
Every figure on this dashboard has a transparent audit trail. With Tracenable, each data point is traceable back to its original source, viewable directly inside our platform. Explore Hansoh Pharmaceutical Group’s data sources below and access millions more through our Disclosure Search.
Insights into Hansoh Pharmaceutical Group's Greenhouse Gas Emissions Pathways
As of 2024, Hansoh Pharmaceutical Group has set greenhouse gas (GHG) emissions reduction targets that cover its operational emissions (Scope 1 and 2), but not its value chain emissions (Scope 3). This means its reduction efforts currently focus on direct and purchased energy emissions.a
Does Hansoh Pharmaceutical Group have a target to reduce the emissions from its operations?
As of 2024, Hansoh Pharmaceutical Group has set a target to reduce its operational greenhouse gas (GHG) emissions, specifically those from Scope 1 and Scope 2 sources.a
Hansoh Pharmaceutical Group's most ambitious operational target is to reduce these emissions by 40% by 2030, compared to a baseline of 0 Metric Tonnes of CO2 equivalent (mtCO2e) per Renminbi/Chinese Yuan (RMB) of Revenue in 2021.a
As of 2024, Hansoh Pharmaceutical Group is ahead of schedule on its operational emissions reduction target, having achieved 82.05% of the planned reduction.a